Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 2:40 AM ET


Company Overview of FermaVir Pharmaceuticals, L.L.C.

Company Overview

FermaVir Pharmaceuticals, L.L.C. researches, develops, and manufactures biotechnology antiviral drugs and solutions for the treatment of shingles, Cytomegalovirus (CMV) infection, and other infections. It holds licensed patents for a series of compounds for the treatment of viral diseases in the United States. It has patents for compounds for the treatment of varicella zoster virus (VZV), the causative agent for shingles and chickenpox, as well as human cytomegalovirus, which includes the viruses that cause chicken pox, mononucleosis, herpes labialis, and genitalis. The company is conducting preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. In addi...

420 Lexington Avenue

Suite 445

New York, NY 10170

United States

1 Employees





Key Executives for FermaVir Pharmaceuticals, L.L.C.

Founder and Director
Age: 73
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Clearant, Inc. United States
Myrmidon Biomaterials Inc. United States
Genzyme General United States
SolaranRx, Inc. United States
Innovative Biologics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact FermaVir Pharmaceuticals, L.L.C., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at